首页 | 本学科首页   官方微博 | 高级检索  
     

沙立度胺单独及联合多柔比星对人肝癌细胞株HepG2中生存素表达的影响
引用本文:韩亚光,崔彦芝,付华斌,曹世堂,陈京莲,何翠. 沙立度胺单独及联合多柔比星对人肝癌细胞株HepG2中生存素表达的影响[J]. 华北国防医药, 2008, 20(5)
作者姓名:韩亚光  崔彦芝  付华斌  曹世堂  陈京莲  何翠
作者单位:[1]解放军白求恩国际和平医院256临床部内科,河北正定050800 [2]南方医科大学南方医院肿瘤中心,广州510515
摘    要:
目的:观察沙立度胺单独及联合多柔比星对人肝癌细胞株HepG2中生存素(Survivin)表达的影响。方法:常规培养人肝癌细胞株HepG2随机分成4组:空白对照组;多柔比星组(1.0mg/L);沙立度胺组(50、100、200、400mg/mL,4个对半稀释质量浓度);联合用药组:沙立度胺(200mg/mL)+多柔比星(1.0mg/L)。分别对HepG2细胞作用12、24、48、72h后,应用免疫组织化学法观察对Survivin表达的影响。结果:沙立度胺单独及联合多柔比星作用于HepG2细胞可下调Survivin表达,单药沙立度胺以200mg/L作用48h效果最为明显,联合用药组下调Survivin表达优于其余各组,差异有统计学意义(P〈0.05)。结论:沙立度胺可下调人肝癌细胞株HepG2Survivin的表达,且与多柔比星有协同作用,可能是沙立度胺抗肿瘤机制之一。

关 键 词:沙立度胺  多柔比星  肝肿瘤  HepG2  生存素  基因表达调控,肿瘤

The Effects of Thalidomide Alone and Combined with Doxorubicin on Survivin Expression in Human Hepatoma HepG2 Cell Lines
HAN Ya-guang,CUI Yan-zhi,FU Hua-bin,CAO Shi-tang,CHEN Jing-lian,HE Cui. The Effects of Thalidomide Alone and Combined with Doxorubicin on Survivin Expression in Human Hepatoma HepG2 Cell Lines[J]. Medical Journal of Beijing Military Region, 2008, 20(5)
Authors:HAN Ya-guang  CUI Yan-zhi  FU Hua-bin  CAO Shi-tang  CHEN Jing-lian  HE Cui
Affiliation:HAN Ya-guang1,CUI Yan-zhi2,FU Hua-bin1,CAO Shi-tang1,CHEN Jing-lian1,HE Cui1(1.Medical Department,the 256th Clinical Branch,Bethune International Peace Hospital of PLA,Zhengding,Hebei 050800,China,2.Department of Oncosis,Nanfang Hospital,NanFang Medical University,Guangzhou 510515,China)
Abstract:
Objective:To investigate the effects of Thalidomide alone and combined with Doxorubicin on Survivin expression in human hepatoma cell lines HepG2 in vitro.Methods:Human hepatoma cell lines HepG2 cultivated by convention,were randomly divided into 4 groups: untreated control group;Doxorubicin group(1.0 mg/L);Thalidomide group(50,100,200,400 mg/mL);drug combination group(Thalidomide 200 mg/mL+Doxorubicin 1.0 mg/L).After HepG2 was treated for 12,24,48,72 hours as described above,the effects on Survivin express...
Keywords:HepG2
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号